Aptevo Therapeutics Inc. (APVO) has 10 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Aug. 10, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 10, 2026 filed Aug. 6, 2026 | Harsanyi Zsolt Director | $0 | 800 | — | No | |
|
|
||||||
| Aug. 10, 2026 filed Aug. 6, 2026 | Lamothe Jeffrey G. President and CEO | $0 | 1,922 | — | No | |
|
|
||||||
| Aug. 10, 2026 filed Aug. 6, 2026 | Taylor Daphne SVP, CFO | $0 | 1,276 | — | No | |
|
|
||||||
| Aug. 10, 2026 filed Aug. 6, 2026 | Kwon SoYoung SVP, GC, BD & Corp Affairs | $0 | 1,276 | — | No | |
|
|
||||||
| Aug. 10, 2026 filed Aug. 6, 2026 | Huebner Dirk SVP, CMO | — | +482 | — | No | |
|
|
||||||
Showing the 5 most recent of 10 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free